Uncovering the Multiple Therapeutic Mechanisms of Trastuzumab Deruxtecan (T-DXd): Effective Extracellular Payload Release and Immunomodulatory Interactions
mRNA-seq data of human macrophages after co-culture with HER2+ breast cancer line Au565 and treated with HER2-targeting therapeutics, including T-DXd, T-DM1 and trastuzumab